Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Now Available in South Florida: CentraSight Treatment Program Offers New Hope for Patients with End-Stage Macular Degeneration

FORT LAUDERDALE, Fla., Feb. 13, 2013 /PRNewswire/ -- The CentraSight™ treatment program, now available at Retina Associates of Miami in South Florida, features the first-ever FDA-approved telescope implant surgical option for patients with End-Stage Age-related Macular Degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans.

(Photo: http://photos.prnewswire.com/prnh/20130213/LA59823)

Smaller than a pea, the telescope implant uses micro-optical technology to magnify images which would normally be seen in one's "straight ahead," or central, vision. The images are projected onto the healthy portion of the retina not affected by the disease.

The telescope implant has been demonstrated in clinical trials to improve quality of life for those with central vision loss in both eyes. It improves patients' vision and returns things most of us take for granted. People regain the ability to see the things that are important to them, increase their independence, and re-engage in everyday activities. They can once again recognize faces and see expressions.

The telescope implant is not a cure for end-stage AMD. As with any medical intervention, potential risks and complications exist with the telescope implant. Possible side effects include decreased vision or vision-impairing corneal swelling.

The first CentraSight Patient Treatment Program team in South Florida includes Dr. J. Harris Levy, MD, Dr. Rashid M. Taher, MD, and Wilfredo C. Lara, MD, who evaluate the patient's medical condition for eligibility certification; Dr. Jesse Pelletier, MD, who performs the implant surgery; and Dr. Marc J. Gannon, OD, FAOO, the low vision specialist who evaluates the patient's visual function and coordinates the post-surgical therapy.

To schedule an evaluation contact Dr. Marc Gannon at 866-942-2020.
Visit www.lowvisioninstitute.com for more information.

About CentraSight
CentraSight is the first-ever telescope implant for end-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans.  Patients with end-stage AMD have a central blind spot or missing area in their vision that makes it difficult or impossible to see faces, read, and perform everyday activities. The CentraSight Treatment Program allows patients to see again by implanting a tiny telescope in the eye in an outpatient procedure, then coordinating with vision specialists to help the patient learn how to use their new vision for everyday activities. For more information visit http://www.centrasight.com/

About Macular Degeneration
More than 15 million Americans are affected by some form of AMD. This number is expected to double by the year 2050.

  • Patients who progress to the end-stage form of AMD have a central blind spot that makes it difficult or impossible for patients to perform everyday activities such as reading, watching TV, preparing meals, and self-care.
  • Macular degeneration attacks the macula, the region of the retina responsible for central, detailed vision. It robs the individual of their central, straight-ahead vision, resulting in what is often referred to as a central vision "blind spot." It does not affect the outer circle of peripheral vision. People see things to the side, but it is too blurry to make up for lost central vision.
  • First signs of AMD: straight lines may appear wavy or disconnected; when looking at a person's face, it is blurred while the rest of the person is in focus; lines of print may be blurred in the center or the lines may be crooked.

CONTACT: Jackie Goldstein
jackieflashgoldstein@gmail.com 
954.849.7971

SOURCE Retina Associates of Miami

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
Satisfying customers and winning their loyalty is the foundation that every successful business is built upon. Delivering a consistently excellent experience builds a level of customer intimacy that will set your business apart from the competition. Consider that 80% of your company’s ...
In 2017, word-of-mouth marketing will be a lucrative strategy and should allow small businesses and startups to carve out powerful niches in a marketplace that's noisier than ever. When was the last time you paused to consider the noise on the internet? If you really take a look, it’s...
Serverless Computing or Functions as a Service (FaaS) is gaining momentum. Amazon is fueling the innovation by expanding Lambda to edge devices and content distribution network. IBM, Microsoft, and Google have their own FaaS offerings in the public cloud. There are over half-a-dozen op...
2016 was a year of dips and dives, twists and turns. Judging by the first couple of weeks of the new year, it’s reasonable to expect 2017 will be another roller coaster year for providers, patients, suppliers and payers. As president and CMO of LeanTaaS, a growth-stage innovator of clo...
There is no more effective way to reduce your overall test environment spend than to migrate to cloud test environments and embrace testing and infrastructure automation. The nature of test environments is inherently temporary—you set up an environment, run through an automated test su...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE